(MENAFN- GlobeNewsWire - Nasdaq) Nuclear medicine equipment, including PET, SPECT, and hybrid imaging systems, is revolutionizing disease diagnosis and treatment by offering precise, non-invasive insights into bodily processes. Critical for detecting cancer, heart, and neurological disorders, these devices use radiopharmaceuticals to capture detailed images, aiding early diagnosis and personalized care. Market growth is driven by rising chronic disease incidence, though challenges like high costs persist. Key players, including Siemens Healthineers, GE Healthcare, and Philips, are advancing the field by integrating AI and ML technologies, enhancing imaging accuracy and personalized treatment plans.

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Equipment Market - A Global and Regional Analysis: Focus on Application, End User, Country, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets's offering.
The global nuclear medicine equipment market is highly competitive, with major players such as Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems, Mediso Medical Imaging Systems, Digirad Corporation, SurgicEye GmbH, DDD-Diagnostic A/S, and Neusoft Medical Systems Co., Ltd. leading the way. These companies are at the forefront of innovation, constantly developing new technologies and enhancing existing products to meet the growing demand for advanced nuclear medicine solutions.
Siemens Healthineers and GE Healthcare dominate the market with their extensive portfolios of imaging systems, including hybrid PET/CT and SPECT/CT scanners, which are essential for accurate diagnostic imaging. Philips Healthcare and Canon Medical Systems also contribute significantly with their high-quality imaging devices that provide enhanced resolution and greater diagnostic precision. Smaller players like Mediso and Digirad focus on niche markets, offering specialized products such as solid-state gamma cameras and compact imaging systems, catering to the growing need for more versatile and affordable solutions.
These companies are also investing heavily in research and development to incorporate the latest advancements, including artificial intelligence, machine learning, and improved radiopharmaceuticals, into their products. Strategic partnerships, acquisitions, and regional expansions are also crucial to maintaining a competitive edge in this rapidly evolving market. As healthcare systems worldwide increasingly adopt nuclear medicine technologies for disease detection and treatment, these market leaders continue to shape the future of the industry.

One of the most significant emerging trends in the global nuclear medicine equipment market is the integration of artificial intelligence (AI) and machine learning (ML) into imaging systems. These technologies are revolutionizing the field by enhancing diagnostic accuracy, optimizing workflows, and enabling personalized treatment planning.
One of the key drivers of the nuclear medicine equipment market is the rising prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and neurological disorders. As these diseases continue to increase globally, there is a growing demand for advanced diagnostic tools that can enable early detection, accurate diagnosis, and effective treatment monitoring. Nuclear medicine plays a critical role in providing precise, non-invasive imaging solutions that allow for the visualization of disease at the molecular level, helping healthcare providers to detect conditions early and tailor personalized treatment plans. The ability to detect and monitor complex diseases using nuclear medicine technologies, such as PET/CT and SPECT/CT scanners, has made these tools invaluable in modern healthcare, driving the market's growth.

AI and ML algorithms are increasingly utilized to analyse complex imaging data from PET/CT and SPECT/CT scans, allowing for more precise detection of abnormalities such as tumours, cardiovascular issues, and neurological disorders. By automating image interpretation and quantifying radiotracer uptake, these technologies assist clinicians in making faster and more accurate diagnoses. Moreover, AI-driven tools facilitate the development of personalized treatment strategies by correlating imaging findings with patient-specific data, leading to tailored therapeutic approaches.
This trend is supported by advancements in hybrid imaging technologies, which combine functional and anatomical imaging modalities, providing comprehensive insights into disease processes. The growing adoption of AI and ML in nuclear medicine is expected to continue, driven by the demand for more efficient, accurate, and personalized healthcare solutions.
Despite the growth of the nuclear medicine equipment market, several challenges persist. One of the primary challenges is the high cost of equipment. Nuclear medicine equipment, such as PET/CT and SPECT/CT scanners, requires significant investment, which can be a barrier for many healthcare facilities, especially those in developing regions or smaller medical centers.
The initial purchase cost, along with maintenance, installation, and operational costs, can be prohibitive for many institutions, limiting the accessibility of advanced diagnostic tools. This high cost can also lead to slower adoption rates, particularly in regions with limited healthcare budgets or inadequate reimbursement systems.
As a result, there is an ongoing need for more cost-effective solutions and financial models that can make nuclear medicine technologies more accessible to a broader range of healthcare providers.
Key Topics Covered:
1. Global Nuclear Medicine Equipment Market: Industry Outlook
1.1 Introduction
1.2 Market Trends
1.3 Regulatory Framework
1.4 Patent Analysis
1.5 Case Studies
1.6 Product Benchmarking
1.7 Market Dynamics
1.7.1 Impact Analysis
1.7.2 Market Drivers
1.7.3 Market Challenges
1.7.4 Market Opportunities
2. Global Nuclear Medicine Equipment Market (by Application), ($Billion), 2024-2035
2.1 Cardiology
2.2 Oncology
2.3 Neurology
2.4 Other Applications
3. Global Nuclear Medicine Equipment Market (by End User), ($Billion), 2024-2035
3.1 Hospitals
3.2 Imaging Centres
3.3 Academic and Research Centres
3.4 Other End Users
4. Global Nuclear Medicine Equipment Market (Region), ($Billion), 2023-2035
4.1 North America
4.1.1 Key Findings
4.1.2 Market Dynamics
4.1.3 Market Sizing and Forecast
4.1.3.1 North America Nuclear Medicine Equipment Market, by Country
4.1.3.1.1 U.S.
4.1.3.1.2 Canada
4.2 Europe
4.3 Asia Pacific
4.4 Rest of the World
5. Global Nuclear Medicine Equipment Market: Competitive Landscape and Company Profiles
5.1 Key Strategies and Development
5.1.1 Mergers and Acquisitions
5.1.2 Synergistic Activities
5.1.3 Business Expansions and Funding
5.1.4 Product Launches and Approvals
5.1.5 Other Activities
5.2 Company Profiles
5.2.1 Overview
5.2.2 Top Products / Product Portfolio
5.2.3 Top Competitors
5.2.4 Target Customers/End-Users
5.2.5 Key Personnel
5.2.6 Analyst View

• Koninklijke Philips N.V.
• Siemens Healthineers AG
• GE Healthcare
• Digirad Corporation
• Mediso Medical Imaging Systems Ltd.
• SurgicEye GmbH
• Canon Medical Systems Corporation
• DDD-Diagnostic A/S
• Neusoft Medical Systems Co., Ltd.
• CMR Naviscan Corporation

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN16102025004107003653ID1110205218